Dna X (SONM) Consolidated Net Income (2018 - 2026)

Dna X (SONM) has 9 years of Consolidated Net Income data on file, last reported at $10.3 million in Q1 2026.

• Quarterly Consolidated Net Income rose 623.61% year-over-year to $10.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.5 million (up 22.86% YoY) and the FY2025 annual result came in at -$12.7 million, up 58.71% from the prior year.
• Consolidated Net Income rose to $10.3 million in Q1 2026, from $3.5 million in the prior quarter.
• In the past five years, Consolidated Net Income ranged from a high of $12.7 million in Q4 2022 to a low of -$7.5 million in Q2 2025.
• A 5-year average of -$33235.3 and a median of -$1.3 million in 2023 frame the typical range for Consolidated Net Income.
• The widest YoY moves for Consolidated Net Income: up 793.47% in 2024, down 1399.8% in 2024.
• Tracing SONM's Consolidated Net Income over 5 years: stood at $12.7 million in 2022, then plunged by 110.13% to -$1.3 million in 2023, then surged by 793.47% to $8.9 million in 2024, then slumped by 61.3% to $3.5 million in 2025, then soared by 197.28% to $10.3 million in 2026.
• The last three Consolidated Net Income figures came in at $10.3 million (Q1 2026), $3.5 million (Q4 2025), and -$4.8 million (Q3 2025), per Business Quant data.